Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Mid Cap Fund median (34 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Midcap 150 history starts 14 Jan 2019, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | ICICI Prudential MidCap Fund |
|---|---|
| 02 Jan 2013 | ₹100.00 |
| 21 Feb 2014 | ₹108.30 |
| 12 Apr 2015 | ₹214.71 |
| 31 May 2016 | ₹199.01 |
| 19 Jul 2017 | ₹275.43 |
| 07 Sep 2018 | ₹300.58 |
| 27 Oct 2019 | ₹281.78 |
| 15 Dec 2020 | ₹348.48 |
| 03 Feb 2022 | ₹517.15 |
| 25 Mar 2023 | ₹495.16 |
| 12 May 2024 | ₹803.02 |
| 01 Jul 2025 | ₹989.24 |
| 20 Aug 2026 | ₹1140.91 |
| Metric | ICICI Prudential · Direct NAV ₹393.27 Very High risk ★★★☆☆ | Category median Mid Cap Fund · 34 funds |
|---|---|---|
| +16.71% | +9.87% | |
| +24.41% | +19.74% | |
| +19.53% | +17.84% | |
| +17.57% | +17.01% | |
| +19.56% | +19.29% | |
| +20.96% | — | |
| +19.37% | +20.53% | |
| +18.04% | +19.07% | |
| +18.49% | +18.49% | |
| Risk | ||
| 17.72% | 16.20% | |
| 1.01 | 0.83 | |
| 1.38 | 1.14 | |
| -44.04% | -32.95% | |
| Nifty Midcap 150 | — | |
| +5.50% | +2.33% | |
| 1.00 | 0.94 | |
| 108.2% | 98.4% | |
| 83.6% | 87.8% | |
| 1.11% | 0.97% | |
| ₹7,594Cr | ₹7,594Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹5.00K | — | |
| 75% | 40% | |
| Lalit Kumar | — | |
| 02 Jan 2013 | — | |
| 80 | — | |
| 38.0% | — | |
| 2.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.